New Service: Alicanto for Antibody Discovery from Human Serum

Jul 14, 2023 | Products, Science

We recently had the pleasure of attending the PEGS Boston Conference. We had the privilege of showcasing our work through a poster presentation, a talk, and an exhibit booth. Among the highlights were engaging with experts, exchanging ideas, and strengthening our network within the community. But perhaps the most important was launching our newest service: Alicanto For Antibody Discovery From Human Serum. It was truly a great time for Abterra Biosciences!

Watch our CEO, Dr. Natalie Castellana’s presentation on Discovering SARS-CoV2 Antibodies From Patient Serum With Alicanto below. This was our first antibody discovery project utilizing human serum!

Click below to watch the presentation.

Customer Spotlight: Dr. Matthew Burchill

Dr. Burchill explains how Valens rescued his antibody and enabled him to continue his research. De novo antibody sequencing case study.

Multi-Species Antibody Repertoire Comparison

Abterra Bio uses Reptor’s antibody repertoire analysis workflow to compare and visualize antibodies from both naïve and immunized animals.

NGS During The Hybridoma Generation Process

Next-generation sequencing (NGS) has allowed for unprecedented insights into patterns of the immune response. It can enable high-throughput sequencing of hybridomas as we have discussed in NGS-Enhanced antibody discovery blog post and resource pages. NGS can provide a...